BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/7/2026 9:40:18 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-01-12 02:58 |
|
Peer-Review Started |
|
2026-01-12 02:58 |
|
First Decision by Editorial Office Director |
|
2026-01-30 08:54 |
|
Return for Revision |
|
2026-01-30 08:54 |
|
Revised |
|
2026-02-11 16:09 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-18 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-18 05:56 |
|
Articles in Press |
|
2026-03-18 05:56 |
|
Edit the Manuscript by Language Editor |
|
2026-03-23 21:13 |
|
Typeset the Manuscript |
|
2026-06-09 03:50 |
|
Publish the Manuscript Online |
|
2026-08-07 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Patient-derived organoids: A new platform for mechanism research and drug development of gastric intestinal metaplasia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jin-Yan Deng, Hong-Bo Du and Xiao-Bin Zao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Bin Zao, Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyuncang Road, Dongcheng District, Beijing 100700, China. a3417@bucm.edu.cn |
| Key Words |
Gastric intestinal metaplasia; Patient-derived organoids; Helicobacter pylori infection; Bile acids; Transgenic mice |
| Core Tip |
Gastric intestinal metaplasia (GIM) is a precancerous lesion in gastric carcinogenesis. Organoid technology has overcome the limitations of previous models by preserving patient-specific molecular features. A recent study by Liu et al identified taurine as a potential drug for suppressing GIM in patient-derived organoids and mouse models. Future research should prioritize the use of patient-derived organoids to study GIM pathogenesis and advance drug development more precisely. |
| Publish Date |
2026-08-07 09:40 |
| Citation |
Deng JY, Du HB, Zao XB. Patient-derived organoids: A new platform for mechanism research and drug development of gastric intestinal metaplasia. World J Gastrointest Oncol 2026; 18(8): 118750
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i8/118750.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i8.118750 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
